Withings unveils Body Pro 3, a cellular scale that splits fat and muscle by limb
Withings Health Solutions announced Body Pro 3, a cellular scale for care programs that measures fat and muscle in each arm, leg and the trunk, with availability in early 2027.
Pulse, covering wearables and health sensors
, 3 min read
Early 2027When Body Pro 3 reaches care programs
What to know
- Body Pro 3 adds a retractable handle so the scale can estimate fat and muscle mass for each arm, each leg and the trunk.
- Withings is selling it to remote patient monitoring providers, enterprise health partners and clinical weight management programs, not in stores.
- A hypertension notification feature is pending FDA 510(k) clearance, and Withings says the scale itself is not FDA cleared.
Withings Health Solutions, the French company's business arm, has announced Body Pro 3, a connected scale that estimates fat and muscle mass separately for each arm, each leg and the trunk. Withings announced it in Boston on November 12, 2026, and showed it at the HLTH USA conference, which ran November 15 to 18. The company says it will be available in early 2027.
Unlike the Withings scales sold in stores, Body Pro 3 is aimed at care teams. The release says it is for enterprise healthcare partners, remote patient monitoring (RPM) providers and clinical weight management programs. Withings did not give a price.
What it measures
The scale has a built-in cellular connection, so a patient does not need to install an app or pair a phone; readings go straight to the care team. Withings' product page says the scale can be shipped to patients through an API call, with Wi-Fi or Bluetooth as a fallback.
A retractable handle is what adds the per-limb readings. With both feet on the plate and the handle in both hands, current can pass through the arms as well as the legs. Withings' product page says the scale uses bioimpedance spectroscopy at 13 frequencies up to 800 kHz across eight electrodes. Besides weight and segmental fat and muscle, the company lists a visceral fat index, heart rate, heart age and vascular age.
Bioimpedance estimates body composition from how easily a small electrical current passes through the body, since muscle holds more water than fat. Readings can shift with hydration, meals and exercise.
The accuracy claim
Withings calls the measurements "DEXA-level," after the low-dose X-ray scan clinics use to measure body composition. Its support for that rests on its own 2025 study with Mon Stade, a sports and health center in France, which compared the scale with DEXA scans in 80 people. The release says readings correlated at 0.99 for fat mass and 0.98 for lean and muscle mass.
A correlation shows that two measurements rise and fall together. It does not show how many kilograms apart they are for a given person, and Withings has not published that figure in the materials we read. The study has not been described as peer reviewed.
Built for GLP-1 programs
Withings is pitching Body Pro 3 at weight-loss programs, including those for people on GLP-1 drugs such as Wegovy and Mounjaro, according to the Swedish site M3. The worry with fast weight loss is losing muscle along with fat, and a scale that splits the two by limb is meant to let a care team see which is happening.
The software forecasts a patient's weight, fat and muscle up to 12 months ahead and adds a goal-probability score and an off-track alert. The release says the models were built on "tens of thousands" of GLP-1 journeys. Withings' page says the projections are statistical estimates, not clinical guarantees.
Regulatory status
A planned hypertension notification feature looks for patterns in weigh-in data that suggest high blood pressure and alerts the care team. It does not measure blood pressure. The release says the feature is pending FDA 510(k) clearance and is not for sale in the United States. Withings' own page says plainly that Body Pro 3 is not FDA cleared. Our explainer on clearance and approval covers what a 510(k) does and does not mean.
Fitt Insider, which called the scale newly launched, reported that Withings formed a medical division this summer.
Why it matters
Body Pro 3 is another sign that weight-loss programs want more than a weight number. Noom is adding its own wrist tracker to employer programs in 2027, and Medicare pays for remote patient monitoring devices that send readings automatically, a market Withings' cellular design is built for. Whether a scale's per-limb estimates are reliable enough for care teams to act on is the open question, and the published evidence so far is one company-run, 80-person comparison. Like cuffless blood pressure wearables, the hypertension feature also still needs the FDA.
This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.
Sources
- Withings Health Solutions Unveils Body Pro 3, Bringing DEXA-Level Segmental Body Composition Tracking Into the Home, Withings via PR Newswire (on Webull), November 12, 2026
- Body Pro 3, Withings product page
- Body Pro 3, M3, November 13, 2026
- Withings Accelerates Growth, Fitt Insider, November 13, 2026
Glucose and metabolic techDigital health and AI in careWearablesHeart health tech
Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.